LifeArc invests in Fluid Biomed
“Fluid Biomed is pioneering a new approach to the treatment of brain aneurysms through its unique bioabsorbable polymer-based stent technology. The ReSolv™ stent, developed by co-founders and leading academic neurosurgeons John Wong, M.D. and Alim Mitha, M.D., has demonstrated functional benefits in a first-in-human clinical study to treat brain aneurysms, a leading cause of stroke and disability. LifeArc Ventures continues to strengthen its focus on groundbreaking medical technology by supporting Fluid Biomed’s Series A financing alongside other leading international investors”
